Stent placement for benign pancreatic diseases: correlation between ERCP findings and clinical response.

Gulliver, David J.; Edmunds, Simon; Baker, Mark E.; Paine, S; Baillie, John; Pb, Cotton; Rice, R P

doi:10.2214/ajr.159.4.1529836

Cited by 39 publications

(23 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…New ductal changes resolved after stent removal in six of the nine patients with normal initial pancreatograms. • Similar results were obtained by Gulliver et al [44]. They followed 29 patients who had had PD stents placed for benign pancreatic disease (although the duration of stent placement was unspecified).…”

Section: Stent Occlusionsupporting

confidence: 78%

Pancreatic duct strictures

Ahmad

Martin

2000

Curr Treat Options Gastro

View full text Add to dashboard Cite

The treatment of pancreatic duct strictures is based on an accurate assessment of the etiology of the disease, and then the degree of symptomatology. Our outline for therapy is as follows: Exclude a diagnosis of malignancy by using radiologic, endoscopic, histologic, and molecular biologic modalities. Once a benign stricture has been demonstrated, we favor a trial of endoscopic dilation and stent placement For the unresectable pancreatic neoplasm, in which an obstructive etiology for pain is suspected, a trial of endoscopic dilation and stent placement also should be considered. In benign pancreatic duct strictures complicated by biliary obstruction, and where the most durable treatment modality is sought, surgical intervention merits earlier consideration. Pancreatic duct stent placement should seldom be considered definitive therapy, and the risk of stent-induced duct injury must be weighed against potential therapeutic benefit.

show abstract

Section: Stent Occlusionsupporting

confidence: 78%

Pancreatic duct strictures

Ahmad

Martin

2000

Curr Treat Options Gastro

View full text Add to dashboard Cite

show abstract

“…38 The transient alteration in duct morphology seems to be due to edema rather than to fi brosis. 40,41 In the present study, there were fi ve patients (21%) with advanced morphological changes dur- ing the 1 year of stent therapy, and transient exacerbation of pancreatitis was seen in three of them at the removal of the fi nal stents. However, there was no correlation between morphological changes and recurrence of any pancreatic symptoms, and the ERP fi ndings improved in three of the fi ve patients 1 year after the stent removal.…”

Section: Discussionmentioning

confidence: 45%

Outcomes after clearance of pancreatic stones with or without pancreatic stenting

et al. 2007

View full text Add to dashboard Cite

show abstract

“…Stenting the pancreatic duct and repeated exchanges of the stent can induce morphological changes in the duct, as well as pseudo− cyst formation, which may lead to worsening of chronic pancrea− titis [12,13]. Sherman et al [12] reported that even short−term pancreatic duct stenting resulted in both ductal and parenchy− mal changes in 56 % of patients with a normal pancreas.…”

Section: Discussionmentioning

confidence: 99%